Simultaneous prophylactic surgery for colon cancer in women. Point of view of gynecologist
Vol. 60 No. 3 (2014), Articles
Vol. 60 No. 3 (2014)

Simultaneous prophylactic surgery for colon cancer in women. Point of view of gynecologist

Articles
https://doi.org/10.37469/0507-3758-2014-60-3-313-318
Published 15.12.2014
N.N. Blokhin Russian Cancer Research Center
N.N. Blokhin Russian Cancer Research Center
N.N. Blokhin Russian Cancer Research Center
N.N. Blokhin Russian Cancer Research Center
N.N. Blokhin Russian Cancer Research Center
##article.numberofdownloads## 21
##article.numberofviews## 88
PDF (Русский)

Keywords

colon cancer
primary multiple malignant tumors

How to Cite

, , , , & . (2014). Simultaneous prophylactic surgery for colon cancer in women. Point of view of gynecologist. Voprosy Onkologii, 60(3), 313–318. https://doi.org/10.37469/0507-3758-2014-60-3-313-318
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Abstract

A 5-year survival of patients with Stage III colon cancer with prophylactic panhysterectomy in anamnesis was 83.3 %, significantly higher than that of patients with Stage III colon cancer without panhysterectomy ( 69.3 %) and than in colon cancer patients with metachronous ovarian metastases (42 %). In families of patients with primary multiple malignant tumors (PMMT) of colon, endometrium and/or ovaries as well as in cases of accumulation in the same family of solitary tumors of the above locations it is necessary to carry out genetic testing to identify mutations in genes MSH2, MLH1, MSH6. Carriers of mutations in genes of mismatch repair MSH2, MLH1, MSH6 should be assumed to the high-risk group for the development of malignancies both PMMT of colon and organs of the female reproductive system and solitary tumors of the above locations. All women suffering from colon cancer, especially in the presence of mutations in genes of mismatch repair, in pre- and menopause should be undergone simultaneous prophylactic surgery: panhysterectomy. The question about the greater omentum should be decided situationally.
https://doi.org/10.37469/0507-3758-2014-60-3-313-318
##article.numberofdownloads## 21
##article.numberofviews## 88
PDF (Русский)

References

Аксель Е.М. Статистика злокачественных новообразований женской половой сферы // Онкогинекология. - 2012. - № 1. - С. 18-23.

Паяниди Ю.Г., Сельчук В.Ю., Жорданиа К.И. и др. Полинеоплазия или метастазы? // Архив пат. - 2006. - № 4. - С. 16-20.

Казубская Т.П., Белев Н.Ф., Нефедов М.Д. и др. Клинико-генетический анализ первично-множественных злокачественных новообразований // Росс. онкол. журн. - 2007. - № 2. - С. 4-9.

Паяниди Ю.Г., Казубская Т.П., Сельчук В.Ю. и др. Гормональная контрацепция и рак: за и против // Онкогинекология. - 2012. - № 3. - С. 10-16.

Geary J., Sasieni P., Houlston R. et al. Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC // Fam Cancer. - 2008. - Vol. 7. - P 163-172.

Lippman S.M., Hawk E.T. Cancer prevention: from 1727 to Milestones of the past 100 years. Cancer Res. - 2009. - Vol. 69. - P. 5269-5284.

Rossel M., Schuffenecker I., Schlumberger M., et al. Detection of a germline mutation at codon 918 of the RET proto-oncogene in French MEN 2B families. // Hum Genet. - 1995. - V.95. - P. 403-406.

All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...